Patent Assignment
Reel/Frame 050801/0267
Security Interest
Recorded: 2019-10-23
Pages: 58
Assignor
INTARCIA THERAPEUTICS, INC.
Executed: 2019-10-04
Assignee
BAUPOST PRIVATE INVESTMENTS BVIV-3, L.L.C., AS COLLATERAL AGENT
10 ST. JAMES AVE, SUITE 1700, BOSTON, MASSACHUSETTS, 02116
Covered Properties
(71)
Osmotic Delivery System Having Space Efficient Piston
Patent:
6,544,252 →
Application:
09/472,600 →
Valve for Osmotic Devices
Patent:
6,508,808 →
Application:
09/748,099 →
Osmotic Implant with Membrane and Membrane Retention Means
Osmotic Delivery Device Having a Two-Way Valve and a Dynamically Self-Adjusting Flow Channel
Valve for Osmotic Devices
Minimally Compliant, Volume-Efficient Piston for Osmotic Drug Delivery Systems
Osmotic Pump with Means for Dissipating Internal Pressure
Osmotically Driven Active Agent Delivery Device Providing an Ascending Release Profile
Osmotic Pump with Self-Retaining, Fast-Start Membrane Plug
Method for Treating Hepatitis C Virus with Omega Interferon
Composition and Dosage Form Comprising an Interferon Particle Formulation and Suspending Vehicle
Minimally Compliant, Volume-Efficient Piston for Osmotic Drug Delivery Systems
Osmotic Delivery Device Having a Two-Way Valve and a Dynamically Self-Adjusting Flow Channel
Solvent/Polymer Solutions as Suspension Vehicles
Implantable Device for Continuous Delivery of Interferon
Polyoxaester Suspending Vehicles for Use with Implantable Delivery Systems
Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator
Osmotic Delivery Systems and Piston Assemblies for Use Therein
Stable Non-Aqueous Single Phase Viscous Vehicles and Formulations Utilizing Such Vehicles
Stable Non- Aqueous Single Phase Viscous Vehicles and Formulations Utlizing Such Vehicles
Suspension Formulations of Insulinotropic Peptides and Uses Thereof
Devices, formulations, and methods for delivery of multiple beneficial agents
Composition and Dosage Form Comprising a Particle Formulation and Suspending Vehicle
Osmotic Delivery Systems and Piston Assemblies for Use Therein
Rapid Establishment and/or Termination of Substantial Steady-State Drug Delivery
Osmotic Drug Delivery Devices Containing Suspension Formulations Comprising Particles Having Active Agents and Nonaqueous Single-Phase Vehicles
An osmotic delivery device comprising an insulinotropic peptide and uses thereof
Osmotic Delivery Systems and Piston Assemblies for Use Therein
Stable Non-Aqueous Single Phase Viscous Vehicles and Formulations Utlizing Such Vehicles
Composition and Dosage Form Comprising a Particle Formulation and Suspending Vehicle
Particle Formulations for Use in Pharmaceutical Compositions
Polyoxaester Suspending Vehicles for Use with Implantable Delivery Systems
Solvent/Polymer Solutions as Suspension Vehicles
Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator
Stable Non-Aqueous Single Phase Viscous Vehicles and Formulations Utilizing Such Vehicles
Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator
Stable Non-Aqueous Single Phase Viscous Vehicles and Formulations Utilizing Such Vehicles
Solvent/Polymer Solutions as Suspension Vehicles
Stable Non-Aqueous Single Phase Viscous Vehicles and Formulations Utilizing Such Vehicles
Methods of Manufacturing Viscous Liquid Pharmaceutical Formulations
Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator
Solvent/Polymer Solutions as Suspension Vehicles
Solvent/Polymer Solutions as Suspension Vehicles
Devices, Formulations, and Methods for Delivery of Multiple Beneficial Agents
Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator
Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator
Osmotic Delivery Systems and Piston Assemblies for Use Therein
Devices, Formulations, and Methods for Delivery of Multiple Beneficial Agents
Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator
Solvent/Polymer Solutions as Suspension Vehicles
THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c
Patent:
9,889,085 →
Application:
14/871,420 →
Implant Placement and Removal Systems
Rapid Establishment and/or Termination of Substantial Steady-State Drug Delivery
Osmotic Delivery Device Comprising an Insulinotropic Peptide and Uses Thereof
Highly Concentrated Drug Particles, Formulations, Suspensions and Uses Thereof
Application:
15/408,112 →
Publication:
US 2017/0119854
Glucagon-Receptor Selective Polypeptides and Methods of Use Thereof
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
Method of Manufacturing an Osmotic Delivery Device
Methods of Manufacturing Viscous Liquid Pharmaceutical Formulations
Application:
15/658,965 →
Publication:
US 2017/0319470
Methods Comprising Continuous Administration of a GLP-1 Receptor Agonist and Co-administration of a Drug
THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c
Devices, Formulations, and Methods for Delivery of Multiple Beneficial Agents
Rapid Establishment and/or Termination of Substantial Steady-State Drug Delivery
Suspension formulation comprising an insulinotropic peptide
Apparatus and Methods for Administration of a Nauseogenic Compound from a Drug Delivery Device
Application:
16/491,275 →
Publication:
US 2020/0188479
Implant Removal Tool
Patent:
860,451 →
Application:
29/566,822 →
Implant Placement Guide
Patent:
840,030 →
Application:
29/566,823 →
Implant Placement Guide
Patent:
835,783 →
Application:
29/604,792 →
Implant Removal Tool and Assembly
Patent:
933,219 →
Application:
29/656,639 →
Implant Placement Guide
Patent:
962,433 →
Application:
29/667,595 →
Human Amylin Analog Polypeptides and Methods of Use
Application:
62/744,236 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 17, 2004
From: DIONNE, KEITH E.; DAVIS, CRAIG R.; PEERY, JOHN R.
To: ALZA CORPORATION
Reel/Frame 016078/0539 →
Change of Name
Jan 13, 2005
From: BIOMEDICINES, INC.
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 016147/0818 →
Assignment of Assignor's Interest
Mar 28, 2005
From: TRAUTMAN, JOSEPH C.
To: ALZA CORPORATION
Reel/Frame 015964/0868 →
Assignment of Assignor's Interest
May 9, 2005
From: CHEN, GUOHUA; AYER, RUPAL A.; LAUTENBACH, SCOTT
To: ALZA CORPORATION
Reel/Frame 016534/0724 →
Assignment of Assignor's Interest
May 10, 2006
From: ROHLOFF, CATHERINE M.; CHEN, GUOHAU; LUK, ANDREW S.; AYER, RUPAL A.
To: ALZA CORPORATION
Reel/Frame 017885/0733 →
Assignment of Assignor's Interest
Jul 5, 2006
From: ROHLOFF, CATHERINE MANYA; BERRY, STEPHEN ANDREW; KANG, LING-LING; NATHAN, ARUNA
To: ALZA CORPORATION
Reel/Frame 017878/0652 →
Assignment of Assignor's Interest
Jul 20, 2006
From: DESJARDIN, MICHAEL A.; LAM, STAN; LIU, KUI; MATSUURA, JAMES E.
To: ALZA CORPORATION
Reel/Frame 017965/0720 →
Assignment of Assignor's Interest
Nov 29, 2006
From: ALZA CORPORATION
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 018562/0963 →
Assignment of Assignor's Interest
Oct 26, 2007
From: ALZA CORPORATION
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 020035/0441 →
Assignment of Assignor's Interest
Nov 19, 2007
From: GILBERT, SCOTT JAY
To: ALZA CORPORATION
Reel/Frame 020141/0354 →
Assignment (Confidential Information, Secrecy and Invention Agreement)
Nov 19, 2007
From: MOSBAUER, ROBERT
To: ALZA CORPORATION
Reel/Frame 020141/0584 →
Assignment of Assignor's Interest
Nov 19, 2007
From: LAUTENBACH, SCOTT D.; DE LA SERNA, PEDRO E.; ZAMORA, PAULINE C.; DESJARDIN, MICHAEL A.
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 020141/0531 →
Assignment of Assignor's Interest
Dec 13, 2007
From: ALZA CORPORATION
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 020252/0143 →
Assignment of Assignor's Interest
Jun 3, 2008
From: ALZA CORPORATION
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 021036/0778 →
Assignment of Assignor's Interest
Jun 9, 2008
From: PEERY, JOHN R.; GILBERT, SCOTT J.; BROWN, JAMES E.
To: ALZA CORPORATION
Reel/Frame 021069/0717 →
Assignment of Assignor's Interest
Jun 9, 2008
From: GILBERT, SCOTT J.
To: ALZA CORPORATION
Reel/Frame 021069/0609 →
Assignment of Assignor's Interest
Oct 8, 2008
From: LAUTENBACH, SCOTT D.; DE LA SEMA, PEDRO E.; ZAMORA. PAULINE C; DESJARDIN, MICHAEL A.
To: ALZA CORPORATION
Reel/Frame 021660/0757 →
Secrecy and Invention Agreement
May 30, 2010
From: DENNIS, PAULA ANN
To: ALZA CORPORATION
Reel/Frame 024456/0669 →
Security Agreement
Sep 8, 2010
From: INTARCIA THERAPEUTICS, INC.
To: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
Reel/Frame 024953/0525 →
Assignment of Assignor's Interest
Aug 9, 2011
From: LAUTENBACH, SCOTT D.; DE LA SERNA, PEDRO E.; ZAMORA, PAULINE C.; DESJARDIN, MICHAEL A.
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026722/0045 →
Release of Security Interest
Sep 23, 2011
From: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026962/0062 →
Security Agreement
Nov 14, 2012
From: INTARCIA THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 029299/0678 →
Assignment of Assignor's Interest
Mar 23, 2015
From: CARR, JOHN; BURDETT DENNIS EXECUTRIX OF ESTATE OF JAMES B. ECKENHOFF, BONNIE
To: ALZA CORPORATION
Reel/Frame 035233/0653 →
Assignment of Assignor's Interest
Mar 23, 2015
From: GILBERT, SCOTT J.
To: ALZA CORPORATION
Reel/Frame 035233/0636 →
Assignment of Assignor's Interest
Mar 25, 2015
From: LAUTENBACH, SCOTT D.
To: ALZA CORPORATION
Reel/Frame 035256/0175 →